Sign in

CIK 0001137883

  • Non-accelerated filer
  • Smaller reporting company

BRAINSTORM CELL THERAPEUTICS INC.

Sign in to watch
Ticker
BCLI
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
207273918
Phone
+1 201-488-0460
Business address
1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
Former names
BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Grant or award Director acquired 12,000 shares (grant or award)
  4. 4 Open-market buy COO and Chief Medical Officer bought 3,000 shares at $3.88 ($11,640)
  5. 4 Open-market buy EVP, CFO and Treasurer bought 11,600 shares at $3.96 ($45,929)
  6. 4 Open-market buy Chief Commercial Officer bought 3,000 shares at $3.90 ($11,700)
  7. 4 Grant or award EVP, CFO and Treasurer acquired 25,000 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market sale Director sold 13,332 shares at $3.67 ($48,891)
  10. 4 Grant or award Lebovits Chaim acquired 31,185 shares (grant or award)
  11. 4 Grant or award COO and Chief Medical Officer acquired 35,885 shares (grant or award)
  12. 4 Grant or award Director acquired 3,501 shares (grant or award)
  13. 4 Open-market buy Director bought 1,475 shares at $3.39 ($5,000)
  14. 4 Gift Director gave 121,558 shares (gift)
  15. 4 Grant or award Director acquired 2,000 shares (grant or award)
  16. 4 Grant or award Director acquired 3,667 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award Director acquired 12,000 shares (grant or award)
  20. 4 Returned to the company Chief Commercial Officer returned 2,805 shares (to the company)

Page 6 of 17 · 329 filings